During the experiment, elevated CD42 levels correlated with increased platelet adhesion and more rapid clot formation at sites of vascular injury.

Measurements showed that patients with low CD18, the beta‑2 integrin subunit that forms membrane-bound complexes with CD11 proteins and whose absence causes leukocyte adhesion deficiency, often have higher disease activity in spondyloarthritis, while elevated plasma levels of its soluble form are inversely correlated with inflammation.

Researchers measured CD11b expression on circulating neutrophils to assess the activation state of the innate immune response.

CD52, a peptide implicated in certain types of lymphoma, is the target of the monoclonal antibody alemtuzumab.

The oncologist ordered immunohistochemistry to check CD30 expression before prescribing brentuximab vedotin.

Researchers measured CD319 expression on bone marrow plasma cells to evaluate response to elotuzumab therapy.

CD150 regulates signaling pathways that influence the activation and survival of T, B, natural killer, and dendritic cells.

Researchers examined how CD46, a membrane protein that acts as an inhibitory complement receptor and serves as an entry point for measles virus, human herpesvirus-6, and Neisseria, mediates pathogen entry and regulates complement activation on host cells.

Epstein-Barr virus attaches to CD21 on B cells to initiate infection.

CD35 is a complement receptor protein that plays a role in immune complex clearance.